greeksoup/ stock research

Johnson & Johnson (JNJ) FY2021 results: revenue $78.7 billion, down 4.7% on the year

Johnson & Johnson (JNJ) reported revenue of $78.7 billion for fiscal 2021, the year ended 2 January 2022, down 4.7% on the year before. Net income was $20.9 billion, up 41.9%, and diluted earnings per share $7.81. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2022.

Revenue
$78.7 billion
-4.7% on the year
FY2014FY2021
Operating margin
n/a
FY2014FY2021
Net income
$20.9 billion
+41.9% on the year
FY2014FY2021
Diluted EPS
$7.81
+41.7% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue78,74082,58482,059-4.7%
Cost of revenue23,40228,42727,556-17.7%
Gross profit55,33854,15754,503+2.2%
Gross margin70.3%65.6%66.4%
Research and development0.012,15911,355
Selling, general and administrative20,11822,08422,178-8.9%
Interest expense183201318-9.0%
Pre-tax income19,17816,49717,328+16.3%
Income tax1,3771,7832,209-22.8%
Effective tax rate7.2%10.8%12.7%
Net income20,87814,71415,119+41.9%
Net margin26.5%17.8%18.4%
Diluted EPS$7.81$5.51$5.63+41.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow23,41023,53623,416-0.5%
Capital expenditure3,6523,3473,498+9.1%
Free cash flow19,75820,18919,918-2.1%
Free cash flow margin25.1%24.4%24.3%
Cash from investing-8,683-20,825-6,194
Cash from financing-14,047-6,120-18,015
Depreciation and amortisation7,3907,2317,009+2.2%
Share-based compensation1,1351,005977+12.9%
Buybacks3,4563,2216,746+7.3%
Dividends paid11,03210,4819,917+5.3%
Dividend per share$4.19$3.98$3.75+5.3%
Diluted shares, weighted2,674m2,671m2,684m+0.1%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity74,02363,27859,471+17.0%
Debt33,75135,26627,696-4.3%
Operating lease liabilitiesn/an/a716
Other liabilities74,24476,35069,845-2.8%
Total liabilities and equity182,018174,894157,728+4.1%
Fixed assets18,96218,76617,658+1.0%
Goodwill25,43636,39333,639-30.1%
Intangible assets46,39253,40247,643-13.1%
Investments17,12111,2001,982+52.9%
Cash and equivalents14,48713,98517,305+3.6%
Receivables15,28313,57614,481+12.6%
Inventory10,3879,3449,020+11.2%
Other assets33,95018,22816,000+86.3%
Total assets182,018174,894157,728+4.1%

10-K for the year ended 2 January 2022, filed 17 February 2022: the filing.